10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2021-08-16 (Q2 2021) | Holdings: 92 | Value: $6.2B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | Add 6% ($51.8M) | 14.37% | $895.4M | +53.23% | +33.74% | -16.47% | |
| NVAX - NOVAVAX INC | Reduce 15% $(93.9M) | 8.72% | $543.5M | -96.79% | -15.45% | -81.91% | |
| FMTX - FORMA THERAPEUTICS HLDGS INC | 3.60% | $224.3M | -13.63% | -48.44% | |||
| JANX - JANUX THERAPEUTICS INC | New Purchase | 3.47% | $216.3M | -15.23% | -33.38% | -53.61% | |
| VOR - VOR BIOPHARMA INC | 3.33% | $207.4M | -98.17% | +25.33% | -58.44% | ||
| AVTE - AEROVATE THERAPEUTICS INC | New Purchase | 3.03% | $188.7M | +13.38% | +78.43% | ||
| NKTX - NKARTA INC | 2.85% | $177.6M | -94.82% | -50.45% | -51.10% | ||
| MGNX - MACROGENICS INC | Add 20% ($27.1M) | 2.56% | $159.6M | -93.62% | -15.80% | -80.24% | |
| CNTB - CONNECT BIOPHARMA HLDGS LTD | Add 134% ($78.1M) | 2.19% | $136.5M | -96.41% | -43.61% | -93.51% | |
| TGTX - TG THERAPEUTICS INC | Reduce 28% $(50.2M) | 2.08% | $129.7M | +78.60% | +23.52% | -66.23% | |
| IMGN - IMMUNOGEN INC | 1.95% | $121.4M | +6.04% | +12.67% | |||
| AVIR - ATEA PHARMACEUTICALS INC | 1.85% | $115.3M | -88.20% | -67.86% | -68.34% | ||
| ITOS - ITEOS THERAPEUTICS INC | 1.82% | $113.3M | -57.92% | +39.81% | -3.56% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | New Purchase | 1.81% | $113.1M | -71.63% | -16.29% | -1.76% | |
| AXSM - AXSOME THERAPEUTICS INC | 1.79% | $111.7M | +427.71% | +64.76% | +105.67% | ||
| PHAT - PHATHOM PHARMACEUTICALS INC | 1.69% | $105.4M | -85.09% | -33.12% | -63.51% | ||
| TIL - INSTIL BIO INC | 1.51% | $94.1M | -90.58% | +33.48% | -57.08% | ||
| RCKT - ROCKET PHARMACEUTICALS INC COM | 1.50% | $93.3M | -90.61% | -8.91% | -40.22% | ||
| ETNB - 89BIO INC | Add 5% ($4.3M) | 1.49% | $92.9M | -45.30% | -10.16% | -73.97% | |
| ZGNX - ZOGENIX INC | 1.47% | $91.3M | +3.10% | ||||
| PCVX - VAXCYTE INC | 1.40% | $87.0M | +34.31% | -3.47% | -3.36% | ||
| KNTE - KINNATE BIOPHARMA INC | 1.34% | $83.6M | +20.47% | -17.77% | |||
| GRPH - GRAPHITE BIO INC | New Purchase | 1.33% | $82.9M | ||||
| TVTX - TRAVERE THERAPEUTICS INC | 1.31% | $81.9M | -13.92% | +70.94% | +62.40% | ||
| HOWL - WEREWOLF THERAPEUTICS INC | New Purchase | 1.20% | $74.8M | -91.15% | +16.91% | -55.61% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | 1.14% | $71.1M | +430.71% | -3.77% | +93.74% | ||
| CYT - CYTEIR THERAPEUTICS INC | New Purchase | 1.12% | $69.5M | -16.65% | -87.01% | ||
| GHRS - GH RESEARCH PLC | New Purchase | 1.04% | $64.7M | -36.95% | +26.20% | -40.00% | |
| OLMA - OLEMA PHARMACEUTICALS INC | 0.97% | $60.2M | -83.76% | -2.43% | -84.92% | ||
| DYN - DYNE THERAPEUTICS INC | 0.95% | $59.0M | -15.57% | -10.02% | -29.09% | ||
| PMVP - PMV PHARMACEUTICALS INC | 0.94% | $58.4M | -97.16% | -27.58% | -54.51% | ||
| KALA - KALA PHARMACEUTICALS INC | 0.93% | $57.6M | -97.05% | -28.62% | -88.32% | ||
| CRIS - CURIS INC | 0.92% | $57.6M | -98.38% | -26.63% | -85.73% | ||
| CERE - CEREVEL THERAPEUTICS HLDNG INC | 0.90% | $56.4M | |||||
| EWTX - EDGEWISE THERAPEUTICS INC | 0.89% | $55.7M | -2.82% | +36.79% | -29.90% | ||
| ORTX - ORCHARD THERAPEUTICS PLC | 0.87% | $54.1M | -43.40% | -78.11% | |||
| SPRY - SILVERBACK THERAPEUTICS INC | 0.86% | $53.8M | |||||
| VERV - VERVE THERAPEUTICS INC | New Purchase | 0.85% | $53.0M | -90.38% | -30.52% | -39.37% | |
| CCCC - C4 THERAPEUTICS INC | 0.84% | $52.1M | -96.18% | +5.97% | -71.04% | ||
| WVE - WAVE LIFE SCIENCES LTD | 0.83% | $51.8M | +14.21% | -29.27% | -41.29% | ||
| TRIL - TRILLIUM THERAPEUTICS INC | 0.82% | $51.3M | |||||
| ACHL - ACHILLES THERAPEUTICS PLC | New Purchase | 0.79% | $49.1M | -10.26% | -45.67% | ||
| CCXI - CHEMOCENTRYX INC | Reduce 2% $(805.7K) | 0.75% | $46.8M | +194.93% | +278.96% | ||
| KALV - KALVISTA PHARMACEUTICALS INC | New Purchase | 0.74% | $46.3M | -25.18% | -4.41% | -17.53% | |
| ARDX - ARDELYX INC | 0.74% | $46.1M | +149.32% | -30.14% | -26.03% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.73% | $45.3M | -88.48% | -14.63% | -65.04% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.70% | $43.5M | -75.22% | +31.72% | +44.18% | ||
| GERN - GERON CORP | 0.68% | $42.5M | +28.93% | +17.36% | +77.69% | ||
| STSA - SATSUMA PHARMACEUTICALS INC | 0.67% | $41.7M | +27.07% | +28.38% | |||
| LEGN - LEGEND BIOTECH CORP | New Purchase | 0.64% | $40.1M | -17.74% | +45.62% | +17.59% | |
| ADVM - ADVERUM BIOTECHNOLOGIES INC | Reduce 100% | 0.00% | $0.00 | ||||
| AKUS - AKOUOS INC | Reduce 100% | 0.00% | $0.00 | ||||
| BDTX - BLACK DIAMOND THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| BOLT - BOLT BIOTHERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | -94.93% | -28.66% | -83.93% | |
| CNST - CONSTELLATION PHARMCETICLS INC | Reduce 100% | 0.00% | $0.00 | ||||
| IGMS - IGM BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| INZY - INOZYME PHARMA INC | Reduce 100% | 0.00% | $0.00 | ||||
| RLAY - RELAY THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | -84.85% | +15.86% | -37.65% | |
| MCRB - SERES THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| STRO - SUTRO BIOPHARMA INC | Reduce 100% | 0.00% | $0.00 | ||||
| VRNA - VERONA PHARMA PLC | Reduce 100% | 0.00% | $0.00 | ||||